Juvan's Health Law & Private Equity Report : Corporate & Health Care Lawyer & Attorney : Jayne Juvan : Benesch Friedlander Law Firm : Private Equity, Corporate Governance

8th Annual MedTech Investing Conference, May 6-7

The 8th Annual MedTech Investing Conference, May 6-7 is right around the corner and looks like it will be a great conference!  I have a conflict and can't attend, but would encourage you to take a minute to view the agenda topics, as well as the stellar line-up of speakers!  Continue reading for a quick over view of the program and registration information.

Continue Reading...

• Email This
• Print
• Comments
• Trackbacks
• Share Link

Interested in learning about acquiring a health care company in bankruptcy?  Then tune into Benesch's webinar entitled A Case Study:  Bankruptcy Acquisition of a Distressed Health Care Enterprise. 

• Email This
• Print
• Comments
• Trackbacks
• Share Link

• Pfizer / Wyeth Transaction.  On January 26, 2009, Pfizer and Wyeth announced that they entered into a definitive merger agreement.  The agreement calls for the acquistion by Pfizer of Wyeth in a cash and stock transaction.  In connection with the transaction, Pfizer announced that the Federal Trade Commission has made a second request for information pursuant to the Hart-Scott-Rodino Antitrust Improvements Act of 1976 regulatory process.  Presumably to resolve post-merger integration concerns, Pfizer also announced today the planned leadership and organizational structure for research and commercial operations.  The company's research structure will have two distinct research organizations - The PharmaTherapeutics Research Group (with a small molecule research focus) and The BioTherapeutics Research Group (with a large molecule research focus), and the company will have nine diverse business segments. 
• Private Equity to Have "Obama" Focus?  The Chicago Tribune reported on an Association of Corporate Growth meeting that questioned whether the private equity industry will experience an "Obama" effect.  The Tribune reported that, among other industries, health care will likely be a focus given the stimulus package.  Indeed, the American Recovery and Reinvestment Act of 2009 (the "Stimulus Bill") makes certain health care companies an attractive investment, as it sets aside $53 billion specifically for health care, along with non-specific spending bringing the total closer to $150 billion.  The Stimulus Bill provides over seven million unemployed Americans and their families with a 65% tax credit for COBRA premiums for up to nine months and gives unemployed workers who failed to elect COBRA coverage within the applicable time frame a second chance to elect coverage.  The Stimulus Bill also provides an estimated $87 billion to states over the next 27 months in the form of a temporary increase in the Federal Medical Assistance Percentage.  While by no means a long-term fix, at least temporarily, these two measures are likely to shore up utilization and stabilize revenues where there may otherwise have been a more considerable decline. The Stimulus Bill also provides incentives for the adoption of health information technology and for clinical preventative services and community-based prevention programs.  

 

• Email This
• Print
• Comments
• Trackbacks
• Share Link